MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-10-2026
Pulmonx Corporation Operating Expenses 2011-2026 | LUNG
Annual Operating Expenses Pulmonx Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121 M | 120 M | 113 M | 98.5 M | 82.9 M | 53.5 M | 40.3 M | 27.3 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 121 M | 27.3 M | 82 M |
Quarterly Operating Expenses Pulmonx Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.4 M | 32 M | 30.9 M | - | 29.2 M | 30.9 M | 28.6 M | - | 28.2 M | 29.2 M | 27 M | - | 24.1 M | 24.8 M | 23.8 M | - | 19.5 M | 21.7 M | 19.1 M | - | 12.8 M | 12.5 M | 11.8 M | - | 10 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 32 M | 10 M | 23.5 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.89 | -0.77 % | $ 145 M |  France |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
614 M | $ 12.72 | 1.27 % | $ 1.91 B | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 31.16 | 0.71 % | $ 1.43 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
InMode Ltd.
INMD
|
136 M | $ 13.79 | 2.53 % | $ 891 M |  Israel |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Aethlon Medical
AEMD
|
9.34 M | $ 2.21 | -1.34 % | $ 3.45 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 265.0 | -1.12 % | $ 7.48 B | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
60 M | $ 2.51 | 2.03 % | $ 147 M | Israel |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 33.63 | -1.18 % | $ 5.01 K | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 10.08 | -3.72 % | $ 1.36 B | USA |
 |
Profound Medical Corp.
PROF
|
33 M | $ 5.16 | -5.67 % | $ 180 M | Canada |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 69.89 | -1.95 % | $ 103 B | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 3.97 | 0.51 % | $ 840 M | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 176.25 | 2.23 % | $ 13.2 B | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 9.18 | -4.42 % | $ 260 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 36.8 | 0.25 % | $ 1.14 B | USA |
 |
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.64 | -1.86 % | $ 34.8 M | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 9.34 | -0.43 % | $ 335 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
40.3 M | $ 23.49 | 1.38 % | $ 199 M | USA |
 |
Establishment Labs Holdings
ESTA
|
185 M | $ 65.53 | 0.05 % | $ 1.94 B |  Costa-rica |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 82.46 | -0.18 % | $ 48.2 B | USA |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.39 | -0.27 % | $ 121 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
547 M | $ 86.3 | -0.32 % | $ 11.7 B | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.11 | 1.93 % | $ 1.28 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 8.9 | - | $ 685 M | USA |